Search result for Chief Executive Officer of Acerus
The new declaration in the pharma industry of the United States
Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) today reported that the amended business organization concurrence with Aytu Bioscience ("Aytu") to quicken the development of NATESTO® in the United States is currently shut and completely viable as of December 1, 2019.
...